KuDOS Pharmaceuticals Limited

Royaume‑Uni

 
Quantité totale PI 44
Rang # Quantité totale PI 31 761
Note d'activité PI 2/5.0    14
Rang # Activité PI 61 542
Parent AstraZeneca PLC

Brevets

Marques

19 0
6 0
19 0
0
 
Dernier brevet 2024 - Immediate release pharmaceutical...
Premier brevet 1998 - Methods and means relating to re...

Derniers inventions, produits et services

2024 Invention Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbony...
2023 Invention Dna damage repair inhibitors for treatment of cancer. The present invention relates to the recog...
2022 Invention Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbon...
2021 Invention Phthalazinone derivatives. Compounds of the formula (I): Compounds of the formula (I): C...
2019 Invention Phthalazinone derivatives. Compounds of the formula (I): 1 is selected from H and halo.
2017 Invention Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors. There is provided a comp...
2014 Invention Phthalazinone derivatives. Compounds of the formula (I): 1 is selected from H and halo.
2010 Invention Dibenzothiophene derivatives as dna- pk inhibitors. Compound formula I: wherein: X1 and X2 may be...
2009 Invention Pharmaceutical formulation 514. The present invention relates to a pharmaceutical formulation com...
Invention Phthalazinone derivative. 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H...
Invention Dna-pk inhibitors. A compound of formula (I) wherein: R1 and R2 are independently selected from ...
Invention Dna-pk inhibitors. A compound of formula (I) wherein: R1 and R2 are independently selected from h...
2008 Invention 4- [3- (4-cyclopropanecarbonyl-piperazine-i-carbonyl) -4 -fluoro-benzyl] -2h-phthalaz in-1-one. 4...
Invention Crystalline form l 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthal...
Invention Atm inhibitors. A compound of formula I: A compound of formula I: A compound of formula ...
Invention Dna-pk inhibitors. A compound of formula I: A compound of formula I: A compound of formu...
Invention Dna-pk inhibitors. A compound of formula (I): wherein: R1 and R2 are independently selected from ...
Invention Dna pk inhibitors. A compound of formula (I): wherein: R1 and R2 are independently selected from ...
Invention Dna-pk inhibitors. A compound of formula I: 1-7 alkyl.
Invention Phthalazinone derivatives and their use as medicament to treat cancer. A compound of the formula ...
Invention Phthalazinone derivatives. A compound of the formula (I): A compound of the formula (I): ...
Invention Phthalazinone derivatives. A compound of the formula (I) wherein: A and B together represent an o...
2007 Invention Phthalazinone derivatives. 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2...
Invention Method of preparing crystalline form phthalazinone derivative for use in cancer treatment. The pr...
Invention Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phtha...
Invention Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors. There is provided a com...
Invention Synthesis of 2-amino-substituted 4-oxo-4h-chromen-8.yl-trifluoro-methanesulfonic acid esters. A ...
Invention 2 -oxyheteroarylamide derivatives as parp inhibitors. A compound of the formula (I): and pharmac...
Invention 2 -oxybenzamide derivatives as parp inhibitors. A compound of the formula (I): and pharmaceutica...
Invention Parp inhibitors. A compound of the formula (I), and pharmaceutically acceptable salts thereof, w...